Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model

Pharmazie

Volumn 67, Issue 11, 2012, Pages 925-929

  Zhuang, Yu Gang ^a   Xu, Bing ^a   Fang, Huang ^a   Wu, Jia Jun ^a   Chen, Sheng ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MITOXANTRONE; PACLITAXEL; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN MCF 7; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; TUMOR VOLUME; ZETA POTENTIAL;

ALGORITHMS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL SURVIVAL; ELECTROCHEMISTRY; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; METHOTREXATE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOXANTRONE; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE;

EID: 84869044140     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.2033     Document Type: Article

References (19)

1. Battaglia L, Serpe L, Muntoni E, Zara G, Trotta M, Gallarate M (2011) Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Nanomedicine 6: 1561-1573.
2. Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR (2003) Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J Pharm Sci 92: 1085-1094. (Pubitemid 36523455)
3. Ewesuedo RB, Ratain MJ (2003) Principles of Cancer Chemotherapy. New York, Springer, p. 19-66.
4. Gasco MR (2001) Solid lipid nanoparticles for drug delivery. Pharm Technol Eur 13: 32-41.
5. Kohler N, Sun C, Wang J, Zhang MQ (2005) Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21: 8858-8864. (Pubitemid 41396647)
6. Lee MK, Lim SJ, Kim C-K (2007) Preparation, characterization and in vitro cytotoxicity of paclitaxel loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28: 2137-2146.
7. Lo YL (2000) Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem Pharmacol 60: 1381-1390.
8. Lu B, Xiong SB, Yang H, Yin XD, Chao RB (2006) Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 28: 86-95.
9. Oussoren C, Eling WMC, Crommelin DJA (1998) The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue local toxicity of two antitumor drugs. Biochim Biophys Acta 1369: 159-172. (Pubitemid 28129268)
10. Oussoren C, Eling WMC, Crommelin DJA (1998) The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue local toxicity of two antitumor drugs. Biochim Biophys Acta 1369: 159-172. (Pubitemid 28129268)
11. Ravi Kumar MNV (2000). Nano and microparticles as controlled drug delivery devices. J Pharm Pharmaceut Sci 3: 234-258.
12. Serpe L, Catalano MG, Cavalli R, Ugazio E, Bosco O, Canaparo R, et al. (2004). Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm 58: 673-680. (Pubitemid 39297116)
13. Singla AK, Garg A, Aggarwal D (2002) paclitaxel and its formulations. Int J Pharm 235: 179-192. (Pubitemid 34185449)
14. Spencer CM, Faulds D (1994) Paclitaxel: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drug 48: 794-847. (Pubitemid 24304427)
15. Tang A, Kopeckova P, Kopecek J (2003) Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes. Pharm Res 20: 360-367. (Pubitemid 36292192)
16. Wong HL, Bendayan R, Rauth AM, Li YQ, Wu XY (2007) Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Delivery Rev 59: 491-504. (Pubitemid 47259227)
17. Yue W, Zhou DJ, Chen S, Brodie A (1994) A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res 54: 5092-5095. (Pubitemid 24313482)
18. Zara GP, Cavalli R, Fundaro A, Bargoni A, Caputo O, Gasco MR (1999) Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). Pharm Res 40: 281-286. (Pubitemid 29435729)
19. Zingler VC, Nabauer M, Jahn K, Grobeta A, Hohlfeld R, Brandt T, Strupp M (2005) Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis. Eur Neurol 54: 28-33. (Pubitemid 41328731)